Waters Corp
About: Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.
Employees: 7,600
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
229% more call options, than puts
Call options by funds: $19.1M | Put options by funds: $5.8M
27% more first-time investments, than exits
New positions opened: 81 | Existing positions closed: 64
2.37% more ownership
Funds ownership: 95.77% [Q1] → 98.13% (+2.37%) [Q2]
1% more funds holding
Funds holding: 755 [Q1] → 759 (+4) [Q2]
1% less repeat investments, than reductions
Existing positions increased: 272 | Existing positions reduced: 275
3% less capital invested
Capital invested by funds: $20.9B [Q1] → $20.4B (-$571M) [Q2]
11% less funds holding in top 10
Funds holding in top 10: 9 [Q1] → 8 (-1) [Q2]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Deutsche Bank
Justin Bowers
|
$315
|
Hold
Maintained
|
5 Aug 2025 |
Wells Fargo
Brandon Couillard
|
$315
|
Equal-Weight
Maintained
|
5 Aug 2025 |
Jefferies
Tycho Peterson
|
$385
|
Buy
Maintained
|
4 Aug 2025 |
Baird
Catherine Ramsey
|
$352
|
Outperform
Maintained
|
16 Jul 2025 |
B of A Securities
Derik De Bruin
|
$375
|
Neutral
Maintained
|
26 Jun 2025 |
Financial journalist opinion
Based on 3 articles about WAT published over the past 30 days